Associations of Gestational Perfluoroalkyl Substances Exposure with Early Childhood BMI


Journal

Environmental health perspectives
ISSN: 1552-9924
Titre abrégé: Environ Health Perspect
Pays: United States
ID NLM: 0330411

Informations de publication

Date de publication:
06 2023
Historique:
medline: 9 6 2023
pubmed: 7 6 2023
entrez: 7 6 2023
Statut: ppublish

Résumé

Gestational per- and polyfluoroalkyl substances (PFAS) exposure may be associated with adiposity and increased risk of obesity among children and adolescents. However, results from epidemiological studies evaluating these associations are inconsistent. We estimated the associations of pregnancy PFAS concentrations with child body mass index (BMI) We used data from 1,391 mother-child pairs who enrolled in eight Environmental influences on Child Health Outcomes (ECHO) cohorts (enrolled: 1999-2019). We quantified concentrations of seven PFAS in maternal plasma or serum in pregnancy. We measured child weight and height between the ages of 2 and 5 y and calculated age- and sex-specific BMI We observed a pattern of subtle positive associations of PFAS concentrations in pregnancy with BMI In eight U.S.-based prospective cohorts, gestational exposure to higher levels of PFAS were associated with slightly higher childhood BMI

Sections du résumé

BACKGROUND
Gestational per- and polyfluoroalkyl substances (PFAS) exposure may be associated with adiposity and increased risk of obesity among children and adolescents. However, results from epidemiological studies evaluating these associations are inconsistent.
OBJECTIVES
We estimated the associations of pregnancy PFAS concentrations with child body mass index (BMI)
METHODS
We used data from 1,391 mother-child pairs who enrolled in eight Environmental influences on Child Health Outcomes (ECHO) cohorts (enrolled: 1999-2019). We quantified concentrations of seven PFAS in maternal plasma or serum in pregnancy. We measured child weight and height between the ages of 2 and 5 y and calculated age- and sex-specific BMI
RESULTS
We observed a pattern of subtle positive associations of PFAS concentrations in pregnancy with BMI
DISCUSSION
In eight U.S.-based prospective cohorts, gestational exposure to higher levels of PFAS were associated with slightly higher childhood BMI

Identifiants

pubmed: 37283528
doi: 10.1289/EHP11545
pmc: PMC10246497
doi:

Substances chimiques

Fluorocarbons 0
Environmental Pollutants 0
Alkanesulfonic Acids 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

67001

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD034568
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023286
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Environ Res. 2016 Aug;149:239-246
pubmed: 27179585
Obes Rev. 2022 Jan;23 Suppl 1:e13383
pubmed: 34766696
BMC Pediatr. 2013 Jun 24;13:99
pubmed: 23799991
Environ Health Perspect. 2022 Mar;130(3):37005
pubmed: 35266797
Metabolomics. 2014 Apr 1;10(2):259-269
pubmed: 25254000
Environ Health Perspect. 2012 Jul;120(7):1036-41
pubmed: 22453676
Metabolomics. 2019 Jun 21;15(7):95
pubmed: 31227916
Endocrinology. 2021 Dec 1;162(12):
pubmed: 34480479
Child Obes. 2020 Apr;16(3):226-233
pubmed: 32191541
Am J Epidemiol. 2013 Sep 15;178(6):921-7
pubmed: 23825166
Environ Health Perspect. 2017 Mar;125(3):467-473
pubmed: 27352404
Environ Epidemiol. 2018 Jun;2(2):
pubmed: 30272047
Pediatr Res. 2022 Nov;92(5):1215-1216
pubmed: 34131291
Environ Int. 2019 Oct;131:104983
pubmed: 31284113
J Chromatogr A. 2011 Apr 15;1218(15):2133-7
pubmed: 21084089
Environ Health Perspect. 2020 Dec;128(12):127014
pubmed: 33356526
Glob Pediatr Health. 2019 Dec 1;6:2333794X19891305
pubmed: 31832491
Toxics. 2021 Jul 14;9(7):
pubmed: 34357911
Pediatr Res. 2022 Nov;92(5):1262-1269
pubmed: 34131290
Child Obes. 2017 Jun;13(3):222-230
pubmed: 28128969
Environ Health Perspect. 2017 Sep 20;125(9):097018
pubmed: 28934720
Environ Int. 2019 Mar;124:482-492
pubmed: 30684806
BMC Med. 2019 Nov 25;17(1):212
pubmed: 31760948
Environ Res. 2022 Nov;214(Pt 3):114021
pubmed: 35952751
Environ Res. 2022 Jan;203:111820
pubmed: 34343551
Curr Environ Health Rep. 2015 Dec;2(4):339-47
pubmed: 26403844
Environ Int. 2019 Mar;124:130-138
pubmed: 30641256
Int J Environ Res Public Health. 2016 Jul 28;13(8):
pubmed: 27483295
Environ Int. 2021 Feb;147:106328
pubmed: 33387879
Environ Health. 2018 Jan 18;17(1):9
pubmed: 29347948
Obesity (Silver Spring). 2016 Jan;24(1):231-7
pubmed: 26554535
Integr Environ Assess Manag. 2011 Oct;7(4):513-41
pubmed: 21793199
Nat Rev Endocrinol. 2017 Mar;13(3):161-173
pubmed: 27857130
Environ Health. 2020 Jul 8;19(1):80
pubmed: 32641055
Sci Rep. 2021 Oct 5;11(1):19789
pubmed: 34611219
Epidemiology. 2014 Mar;25(2):255-64
pubmed: 24407430
Environ Int. 2018 Feb;111:191-199
pubmed: 29223808
J Epidemiol Community Health. 2017 Feb;71(2):162-173
pubmed: 27480843
Environ Health Perspect. 2012 Oct;120(10):1432-7
pubmed: 22935244
Endocrinology. 2006 Jun;147(6 Suppl):S50-5
pubmed: 16690801
Int J Obes (Lond). 2021 Jan;45(1):25-35
pubmed: 33208860
Int J Environ Res Public Health. 2021 Feb 03;18(4):
pubmed: 33546139
Am J Epidemiol. 2018 Apr 1;187(4):793-802
pubmed: 29155920
Environ Health Perspect. 2010 May;118(5):686-92
pubmed: 20089479
Int J Epidemiol. 2013 Apr;42(2):627-34
pubmed: 23569196
Environ Health Perspect. 2017 Jun 23;125(6):067013
pubmed: 28665274
Environ Sci Technol. 2020 Dec 15;54(24):16039-16049
pubmed: 33269902
Chemosphere. 2019 Jul;226:17-23
pubmed: 30908964
PLoS One. 2018 May 10;13(5):e0197244
pubmed: 29746532
Reprod Toxicol. 2019 Aug;87:70-78
pubmed: 31121237
PLoS Med. 2019 Jun 11;16(6):e1002817
pubmed: 31185012
Toxicology. 2020 Oct;443:152565
pubmed: 32861749
Environ Int. 2021 Dec;157:106789
pubmed: 34333293
Environ Health Perspect. 2020 Jul;128(7):77001
pubmed: 32628516
Front Toxicol. 2020 Dec 04;2:601149
pubmed: 35296120
Pediatr Res. 2020 May;87(6):1093-1099
pubmed: 31835271
J Expo Sci Environ Epidemiol. 2019 Mar;29(2):131-147
pubmed: 30470793
JAMA Netw Open. 2022 Feb 1;5(2):e2146873
pubmed: 35119461
Toxicol Appl Pharmacol. 2014 Sep 15;279(3):275-283
pubmed: 24998974
J Altern Complement Med. 2002 Apr;8(2):185-92
pubmed: 12006126
Int J Environ Res Public Health. 2021 Jan 16;18(2):
pubmed: 33467168

Auteurs

Yun Liu (Y)

Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island, USA.

Adaeze C Wosu (AC)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Abby F Fleisch (AF)

Pediatric Endocrinology and Diabetes, Maine Medical Center and Maine Medical Center Research Institute, Portland, Maine, USA.
Center for Outcomes Research and Evaluation, Maine Medical Center and Maine Medical Center Research Institute, Portland, Maine, USA.

Anne L Dunlop (AL)

Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia, USA.

Anne P Starling (AP)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Lifecourse Epidemiology of Adiposity and Diabetes Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

Assiamira Ferrara (A)

Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.

Dana Dabelea (D)

Lifecourse Epidemiology of Adiposity and Diabetes Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

Emily Oken (E)

Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.

Jessie P Buckley (JP)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Leda Chatzi (L)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Margaret R Karagas (MR)

Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, USA.

Megan E Romano (ME)

Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, USA.

Susan Schantz (S)

Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.

Thomas G O'Connor (TG)

Department of Psychiatry, University of Rochester, Rochester, New York, USA.

Tracey J Woodruff (TJ)

Program on Reproductive Health and the Environment, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, California, USA.

Yeyi Zhu (Y)

Lifecourse Epidemiology of Adiposity and Diabetes Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

Ghassan B Hamra (GB)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Joseph M Braun (JM)

Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH